Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study it to determine the safety and maximally tolerated dose (MTD) of
cisplatin administered in the operating room and put into the chest and abdomen for one hour.
We are also looking at the effects of heating the chemotherapy to a temperature of 42 degrees
celsius.